These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6217207)

  • 1. Purification and characterization of the biliary plasminogen activator bilokinase.
    Oshiba S; Ariga T
    J Biol Chem; 1983 Jan; 258(1):622-8. PubMed ID: 6217207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on bilokinase, a biliary plasminogen activator: immunologic property and organ distribution.
    Ariga T; Oshiba S; Seki T; Imai H; Imai S; Sawai H
    Thromb Res; 1989 Oct; 56(1):37-48. PubMed ID: 2688187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Purification and characterization of bilokinase, a biliary plasminogen activator.
    Oshiba S; Ariga T
    Thromb Diath Haemorrh; 1975 Sep; 34(1):319. PubMed ID: 1237947
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification and some properties of urokinase.
    Ogawa N; Yamamoto H; Katamine T; Tajima H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):194-209. PubMed ID: 242089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
    Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
    Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kinetics of urokinase hydrolysis of low molecular weight substrates].
    Maksimenko AV; Torchilin VP; Smirnov VN
    Biokhimiia; 1982 Mar; 47(3):405-8. PubMed ID: 7041994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic studies of urokinase-catalysed hydrolysis of 5-oxo-L-prolylglycyl-L-arginine 4-nitroanilide.
    Ipsen HH; Christensen U
    Biochim Biophys Acta; 1980 Jun; 613(2):476-81. PubMed ID: 6449958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic studies of the urokinase catalysed conversion of NH2-terminal lysine plasminogen to plasmin.
    Christensen U; Müllertz S
    Biochim Biophys Acta; 1977 Jan; 480(1):275-81. PubMed ID: 137749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proceedings: 70. Studies on the fibrinolytic enzymes in hepatobiliary systems. 4. Especially on purification and characterization of bilokinase (author's transl)].
    Oshiba S; Ariga T; Kobayashi K; Sawai H
    Nihon Seirigaku Zasshi; 1973; 35(8):410-1. PubMed ID: 4799271
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functionally active heavy chain derived from human high molecular weight urokinase.
    Sumi H; Robbins KC
    J Biol Chem; 1983 Jul; 258(13):8014-9. PubMed ID: 6345538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and thrombolytic properties of a low molecular weight form (comprising Leu144 through Leu411) of recombinant single-chain urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Holmes WE; Collen D
    J Biol Chem; 1988 Apr; 263(12):5594-8. PubMed ID: 2965704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L; Lijnen HR; Collen D; Holmes WE
    J Biol Chem; 1987 Aug; 262(22):10855-62. PubMed ID: 2956260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiological studies on the plasminogen-activator (bilokinase) found in the hepatic bile of dogs].
    Fukumoto R
    Nihon Seirigaku Zasshi; 1968; 30(7):464-71. PubMed ID: 5749260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.